Delivery Order SPE2DB24D3013-SPE2DB25FFRAM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,844.50 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation solution (4 gm). This competitively awarded, firm fixed-price contract has a completion date of June 11, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $7,413.38 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 gram formulation) on September 11, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $13,429.73 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 grams) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction under...
- The Defense Logistics Agency awarded a $3,470.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Spiriva Respimat 1.25 mcg inhalation medication in 4-gram quantities. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside designation. Performance will be completed at the...
- The Defense Logistics Agency awarded a $2,276.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 grams) on September 26, 2025, with completion expected by September 29, 2025. This non-set-aside contract represents a small-value pharmaceutical delivery supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,086.40 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 grams) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalant (4 gm) with a ceiling value of $1,651.33. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,848.20 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 grams) with a completion date of August 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Spiriva Respimat 2.5 mcg inhaler (4 grams) with a ceiling value of $1,629.61. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract is scheduled for completion by September 15, 2025, with fulfillment from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFRAMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,639.67 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhalation solution (4 gm) on September 26, 2025, with completion scheduled for September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's federal contract awards demonstrate its capability to fulfill diverse medical supply requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for the respiratory medication reflects the contractor's ongoing role in supporting military medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/26/25 |